首页> 外国专利> Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents

Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents

机译:聚合物植入物,优选包含PEG和PLG的混合物,用于控制活性剂的释放

摘要

Polymeric devices for controlled release of an active agent of interest are provided. The active agent is provided within a biodegradable polymer system to supply a polymeric device for controlled release of the active agent. The polymer system is a copolymer or a polymer blend comprising a hydrophobic component and a hydrophilic component, and the polymer system does not form a hydrogel when contacted with, or immersed in an aqueous system, for example when the device is implanted in a subject. When the device is administered to a subject, for example, when it is implanted, the device releases the active agent in a controlled fashion without a lag period, or with a minimal lag period. Methods for producing the polymeric devices are also provided, as are methods of using the polymeric devices to provide for controlled release of an active agent in a subject. Preferred hydrophobic component is a PLG. Preferred hydrophilic Components are a PEG or a methoxyPEG. Preferred peptides are LHRH, goserelin, leuprolide.
机译:提供了用于控制释放感兴趣的活性剂的聚合物装置。活性剂被提供在可生物降解的聚合物系统中,以提供用于控制释放活性剂的聚合物装置。该聚合物体系是包含疏水性组分和亲水性组分的共聚物或聚合物共混物,并且当与该体系接触或浸入其中时,例如当将该装置植入受试者体内时,该聚合物体系不会形成水凝胶。当将该装置施用于受试者时,例如当其被植入时,该装置以受控的方式释放活性剂而没有滞后时间或具有最小的滞后时间。还提供了生产聚合物装置的方法,以及使用聚合物装置以提供活性剂在受试者中的受控释放的方法。优选的疏水性组分是PLG。优选的亲水性组分是PEG或甲氧基PEG。优选的肽是LHRH,戈舍瑞林,亮丙瑞林。

著录项

  • 公开/公告号EP2286791B1

    专利类型

  • 公开/公告日2014-03-26

    原文格式PDF

  • 申请/专利权人 DURECT CORP;

    申请/专利号EP20100010150

  • 发明设计人 TIPTON ARTHUR J.;GIBSON JOHN W.;

    申请日2004-12-23

  • 分类号A61K9/00;A61K38/00;A61K9/16;

  • 国家 EP

  • 入库时间 2022-08-21 15:50:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号